Roche Coba Slater Difficult Clostridium difficile rapid test reagent - Taiwan Registration ecd51e5abd3b59de2e071170d406cc4c
Access comprehensive regulatory information for Roche Coba Slater Difficult Clostridium difficile rapid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ecd51e5abd3b59de2e071170d406cc4c and manufactured by Roche Molecular Systems, Inc.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is an automated qualitative in vitro diagnostic test for the cobas Liat system, using real-time polymerase chain reaction (PCR) to detect toxin B (tcd B) genes in Clostridium difficile obtained from patients suspected of Clostridium difficile infection (CDI).
C Immunology and Microbiology; A Clinical chemistry and clinical toxicology
C.3130 Clostridium Dystoxin Gene Enhancement Agent;; A.1660 Quality control materials (analytical and non-analytical)
import
Dates and Status
May 10, 2018
May 10, 2028